VIENNA, Va. - eTradeWire -- AZ Diabetic, a leading provider of innovative diabetic care solutions, is thrilled to announce the upcoming availability of over-the-counter (OTC) continuous glucose monitoring (CGM) systems. Starting in the summer of 2024, the highly anticipated Abbott Lingo and Dexcom Stelo systems will be available for purchase without a prescription, offering unprecedented accessibility and convenience for diabetes management.

Continuous glucose monitoring is a transformative advancement in diabetes care. Unlike traditional finger-stick tests, CGM systems provide real-time data by continuously measuring glucose levels. This technology empowers users with immediate insights into their glucose levels, enabling better decision-making for diet, exercise and medication adjustments.

The CGM systems that will be available through AZ Diabetic include:

Abbott Lingo: Renowned for its accuracy and user-friendly interface, the Abbott Lingo system features a small sensor inserted just under the skin. This sensor continuously monitors glucose levels and sends data wirelessly to a receiver or smartphone app, providing real-time readings and trends.

More on eTradeWire News

• Simplicity Design Agency Launches AI Division: Merging 20 Years of Design & Tech
• Exciting News for Military Spouses! EvereTech Is Now an Approved MyCAA Vendor
• Columbia U's Sanctuary Campus - It's Possible
• Raising a Glass for Good: Salida Wine Festival 2026 Teams Up with The Alliance in Chaffee County
• Non‑Surgical Option for Benign Thyroid Nodule Treatment with Dr. Richard Harding in Arizona

Dexcom Stelo: Celebrated for its reliability and seamless integration with smart devices, the Dexcom Stelo system also includes a minimally invasive sensor and a transmitter that communicates glucose data wirelessly. The information is accessible via a smartphone app, allowing users to effortlessly track their glucose levels.

"At AZ Diabetic, we are committed to enhancing the lives of those managing diabetes by providing cutting-edge technology that is both accessible and easy to use," said Sam, CEO of AZ Diabetic. "The release of the Abbott Lingo and Dexcom Stelo systems this summer aligns with our mission to empower individuals with the tools they need to take control of their health."

The launch of these OTC CGM systems marks a significant milestone in diabetes care. By eliminating the need for a prescription, AZ Diabetic ensures that more individuals have access to this life-changing technology, promoting better health outcomes and improving the quality of life for those living with diabetes.

For more information about AZ Diabetic and to purchase the Abbott Lingo or Dexcom Stelo CGM systems starting in the summer of 2024, please visit https://www.azdiabetic.com/cgm-otc or call 877-883-0001.